Found: 72
Select item for more details and to access through your institution.
Parkinson's disease clinical milestones and mortality.
- Published in:
- NPJ Parkinson's Disease, 2022, p. 1, doi. 10.1038/s41531-022-00320-z
- By:
- Publication type:
- Article
A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00196-5
- By:
- Publication type:
- Article
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, n. 6, p. 980, doi. 10.1002/mdc3.13752
- By:
- Publication type:
- Article
Common gene expression signatures in Parkinson's disease are driven by changes in cell composition.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-00932-7
- By:
- Publication type:
- Article
Excessive Daytime Sleepiness and REM Sleep Behavior Disorders in Parkinson's Disease: A Narrative Review on Early Intervention With Implications to Neuroprotection.
- Published in:
- Frontiers in Neurology, 2018, p. N.PAG, doi. 10.3389/fneur.2018.00961
- By:
- Publication type:
- Article
No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- Letter
GCase activity and long‐term risk of dementia in Parkinson's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.064512
- By:
- Publication type:
- Article
Long‐term cognitive and motor decline across the spectrum of Lewy body disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055180
- By:
- Publication type:
- Article
Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 10, p. 1293, doi. 10.1016/j.jalz.2018.04.006
- By:
- Publication type:
- Article
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211060337
- By:
- Publication type:
- Article
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 4, p. 1, doi. 10.1177/20552173211060337
- By:
- Publication type:
- Article
Validation of a new assay for α-synuclein detection in cerebrospinal fluid.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2017, v. 55, n. 2, p. 254, doi. 10.1515/cclm-2016-0409
- By:
- Publication type:
- Article
Memory impairment is associated with hippocampal atrophy in newly diagnosed Parkinson's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Memory impairment is associated with hippocampal atrophy in newly diagnosed Parkinson's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
CSF Abeta and tau, hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease with and without mild cognitive impairment
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease subjects with mild cognitive impairment
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Hippocampal Atrophy and Lateral Ventricle Enlargement in Parkinson's Disease Subjects with Mild Cognitive Impairment
- Published in:
- 2010
- By:
- Publication type:
- Abstract
CSF Abeta and tau, hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease with and without mild cognitive impairment
- Published in:
- 2010
- By:
- Publication type:
- Abstract
P3-087: Neuropsychiatric correlates of CSF Tau and P-Tau in dementia
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P2-215: REM sleep behavior disorder and other sleep problems in mild dementia
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.
- Published in:
- Frontiers in Aging Neuroscience, 2016, p. 1, doi. 10.3389/fnagi.2016.00147
- By:
- Publication type:
- Article
Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.
- Published in:
- Frontiers in Aging Neuroscience, 2016, p. 1, doi. 10.3389/fnagi.2016.00121
- By:
- Publication type:
- Article
A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143969
- By:
- Publication type:
- Article
LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation.
- Published in:
- Journal of Neuroscience Research, 2016, v. 94, n. 8, p. 717, doi. 10.1002/jnr.23754
- By:
- Publication type:
- Article
Differential transcript usage in the Parkinson's disease brain.
- Published in:
- PLoS Genetics, 2020, v. 16, n. 11, p. 1, doi. 10.1371/journal.pgen.1009182
- By:
- Publication type:
- Article
Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study.
- Published in:
- Journal of Neurology, 2010, v. 257, n. 2, p. 217, doi. 10.1007/s00415-009-5297-x
- By:
- Publication type:
- Article
Epidemiology of Parkinson’s disease.
- Published in:
- Journal of Neurology, 2008, v. 255, p. 18, doi. 10.1007/s00415-008-5004-3
- By:
- Publication type:
- Article
Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2008, v. 25, n. 6, p. 559, doi. 10.1159/000137671
- By:
- Publication type:
- Article
Early Forms of α -Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson's Disease.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 6, p. 747, doi. 10.3390/biom12060747
- By:
- Publication type:
- Article
APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study.
- Published in:
- Journal of Geriatric Psychiatry & Neurology, 2009, v. 22, n. 3, p. 166, doi. 10.1177/0891988709332945
- By:
- Publication type:
- Article
Prognosis of Mild Cognitive Impairment in Early Parkinson Disease.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 5, p. 580, doi. 10.1001/jamaneurol.2013.2110
- By:
- Publication type:
- Article
Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0239824
- By:
- Publication type:
- Article
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.
- Published in:
- Cellular & Molecular Life Sciences, 2016, v. 73, n. 4, p. 811, doi. 10.1007/s00018-015-2093-x
- By:
- Publication type:
- Article
Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson's Disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00768-1
- By:
- Publication type:
- Article
Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 6, p. 3064, doi. 10.1007/s00415-021-10893-z
- By:
- Publication type:
- Article
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 4, p. 1385, doi. 10.1007/s00415-020-10290-y
- By:
- Publication type:
- Article
Evolution of impulsive–compulsive behaviors and cognition in Parkinson's disease.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 1, p. 259, doi. 10.1007/s00415-019-09584-7
- By:
- Publication type:
- Article
Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 2, p. 364, doi. 10.1007/s00415-016-8365-z
- By:
- Publication type:
- Article
Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-79104-5
- By:
- Publication type:
- Article
Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.620585
- By:
- Publication type:
- Article
Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study.
- Published in:
- Acta Neurologica Scandinavica, 2023, p. 1, doi. 10.1155/2023/7136599
- By:
- Publication type:
- Article
Cannabis use in Parkinson's disease—A nationwide online survey study.
- Published in:
- Acta Neurologica Scandinavica, 2022, v. 145, n. 6, p. 692, doi. 10.1111/ane.13602
- By:
- Publication type:
- Article
Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease.
- Published in:
- Acta Neurologica Scandinavica, 2018, v. 138, n. 6, p. 508, doi. 10.1111/ane.13003
- By:
- Publication type:
- Article
Letter to the editor in response to the letter from the EPIPARK Study Group regarding the publication ʻProgression of fatigue in Parkinson's disease ‐ a 9‐year follow‐upʼ (Eur J Neurol 2021. doi:10.1111/ene.14520).
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 6, p. e33, doi. 10.1111/ene.14765
- By:
- Publication type:
- Article
Fatigue in Parkinson’s Disease: A Proteomic Study of Cerebrospinal Fluid.
- Published in:
- Movement Disorders, 2024, v. 39, n. 4, p. 749, doi. 10.1002/mds.29715
- By:
- Publication type:
- Article
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study.
- Published in:
- Movement Disorders, 2022, v. 37, n. 5, p. 1016, doi. 10.1002/mds.28932
- By:
- Publication type:
- Article
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD.
- Published in:
- Neuroepidemiology, 2015, v. 45, n. 4, p. 282, doi. 10.1159/000439221
- By:
- Publication type:
- Article
Cognitive Profile in Parkinson's Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta.
- Published in:
- Dementia & Geriatric Cognitive Disorders Extra, 2023, v. 13, n. 1, p. 39, doi. 10.1159/000534552
- By:
- Publication type:
- Article
E. DIETRICHS OG MEDARBEIDERE SVARER.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2023, v. 143, n. 14, p. 1198
- By:
- Publication type:
- Article